Criteria for the clinical use of intravenous immunoglobulin in Australia
Second Edition Quick Reference Guide
The following index lists the same medical conditions as in the Alphabetical Index above, but by therapeutic role as they appear in Chapters 5 through to 8 of the full Criteria as follows:
| Chapter 5 | Established therapeutic role |
| Chapter 6 | Emerging therapeutic role |
| Chapter 7 | Use in exceptional circumstance only |
| Chapter 8 | Use of IVIg is not supported |
The above colour coding has been applied throughout the remainder of the QRG to identify relevant role in therapy conditions for which IVIg has an established therapeutic role
| Conditions for which IVIg use is not supported – not funded under the national Blood Arrangements | |
|---|---|
| Acute optic neuritis | Henoch–Schonlein purpura |
| Acute rheumatic fever | HIV/AIDS — adult |
| Adrenoleukodystrophy | Idiopathic dilated cardiomyopathy |
| Amegakaryocytic thrombocytopenia | Linear IgA disease |
| Antiphospholipid syndrome (non-obstetric) | Lupus cerebritis |
| Aplastic anaemia/pancytopenia | Lupus nephritis |
| Asthma | Motor neuron disease/amyotrophic lateral sclerosis |
| Atopic dermatitis/eczema — adult | Myalgic encephalomyelitis |
| Autism | Narcolepsy/cataplexy |
| Autologous haemopoietic stem cell transplantation | Nephrotic syndrome |
| Behçet’s disease | Obsessive compulsive disorders |
| Cardiac surgery with bypass — prophylaxis | Polyneuropathy of critical illness |
| Congestive cardiac failure | Recurrent foetal loss (with or without antiphospholipid syndrome) |
| Crohn’s disease | Rheumatoid arthritis |
| Diamond Blackfan syndrome | Sepsis |
| Female infertility | Sickle cell disease |
| Glomerulonephritis — IgA nephritis | Systemic lupus erythematosus |
| Haemolytic uraemic syndrome | Ulcerative colitis |